Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hzymes Biotechnology
company
About
Is a high-tech enterprise focusing on R&D, manufacture, and sales of in vitro diagnostic (IVD) products.
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥800M
- Industries
- Manufacturing
- Founded date
- Jan 1, 2015
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥800M
Hzymes Biotechnology has raised a total of
¥800M
in funding over 2 rounds. Their latest funding was raised on
Nov 10, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 10, 2021 | Series C | ¥800M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Hzymes Biotechnology is funded by 1 investors.
Guangfa Qianhe Investment Co.
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
